Insys Therapeutics, Inc. Interest Expense
Insys Therapeutics, Inc. reported Interest Expense of $950.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-02-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2016-02-29
- Insys Therapeutics, Inc. interest expense for the quarter ending 2013-12-31 was $13.00K, a 98.13% decline year-over-year.
- Insys Therapeutics, Inc. interest expense for the quarter ending 2013-09-30 was -$8.00K, a 101.18% decline year-over-year.
- Insys Therapeutics, Inc. interest expense for the quarter ending 2013-06-30 was $272.00K, a 59.58% decline year-over-year.
- Insys Therapeutics, Inc. interest expense for the quarter ending 2013-03-31 was $673.00K, a 5.49% increase year-over-year.
- Insys Therapeutics, Inc. interest expense for fiscal 2013 was $950.00K, a 64.61% decline from fiscal 2012.
- Insys Therapeutics, Inc. interest expense for fiscal 2012 was $2.68M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2013-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.00K derived: sum of 2 quarters · filed 2016-02-29 | $277.00K derived: sum of 3 quarters · filed 2016-02-29 | $950.00K 10-K · filed 2016-02-29 | $928.00K 10-K · filed 2014-03-05 |
| 2013-09-30 | -$8.00K 10-Q · filed 2013-11-12 | $264.00K derived: sum of 2 quarters · filed 2014-08-12 | $937.00K 10-Q · filed 2013-11-12 | $1.63M derived: sum of 4 quarters · filed 2014-08-12 | |
| 2013-06-30 | $272.00K 10-Q · filed 2014-08-12 | $945.00K 10-Q · filed 2014-08-12 | $1.64M derived: sum of 3 quarters · filed 2014-08-12 | $2.32M derived: sum of 4 quarters · filed 2014-08-12 | |
| 2013-03-31 | $673.00K 10-Q · filed 2014-05-14 | $1.37M derived: sum of 2 quarters · filed 2014-05-14 | $2.05M derived: sum of 3 quarters · filed 2014-05-14 | $2.72M derived: sum of 4 quarters · filed 2014-05-14 | |
| 2012-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $1.37M derived: sum of 2 quarters · filed 2014-03-05 | $2.05M derived: sum of 3 quarters · filed 2014-03-05 | $2.68M 10-K · filed 2014-03-05 | |
| 2012-09-30 | $679.00K 10-Q · filed 2013-11-12 | $1.35M derived: sum of 2 quarters · filed 2013-11-12 | $1.99M 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $673.00K 10-Q · filed 2013-08-13 | $1.31M 10-Q · filed 2013-08-13 | |||
| 2012-03-31 | $638.00K 10-Q · filed 2013-06-05 |